According to a new market analysis, the global Assisted Reproductive Technology market was valued at USD 44 billion in 2023 and is projected to reach USD 55.63 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period (2024-2030). The growth is fueled by rising infertility rates, technological advancements in IVF treatments, and increasing government support for fertility solutions.
What is Assisted Reproductive Technology?
Assisted Reproductive Technology (ART) refers to medical procedures utilized primarily to address infertility where both eggs and sperm are handled. This includes in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation of gametes/embryos, and fertility medications. ART has revolutionized family planning, offering solutions to an estimated 1 in 6 couples globally facing fertility challenges, according to WHO data.
Download FREE Sample Report:
Assisted Reproductive Technology Market – View Detailed Research Report
Drivers
- Rising Infertility Rates: Infertility is on the rise as a result of delayed childbearing, lifestyle, and environmental influences. The World Health Organization (WHO) reports that 1 in every 6 couples across the globe suffers from infertility, which has created increased demand for fertility treatments such as IVF.
- Technological Advancements: Constant innovation in IVF technology, e.g., genetic screening, freezing of embryos, and artificial ininformigence-powered diagnostics, has dramatically increased success rates. PGT-A (Preimplantation Genetic Testing for Aneuploidy), has enhanced IVF success by mitigating the chance of miscarriage and enhancing the quality of the embryo, assisting in raising the world IVF success rate to about 44.5% in women younger than 35.
- Delayed Childbearing: With more individuals delaying parenthood for career and personal reasons, ART is becoming a preferred solution. More women are postponing parenthood based on career, financial, and lifestyle reasons. The age of first-time mothers is increasing steadily in nations such as the U.S. and Europe. Based on CDC statistics, the age of first-time mothers in the U.S. is now 26.9 years, which is cautilizing an increased demand for IVF since fertility decreases with age, particularly after 35.
- Government Support: Subsidies and health insurance coverage for ART treatments are growing in developed countries.
Opportunities
- Emerging Markets: Regions like Southeast Asia, the Middle East, and Latin America present strong growth potential due to rising fertility clinics and supportive policies.
- Cryopreservation Demand: The increasing trconclude of egg and embryo freezing is generating a new revenue stream for clinics.
- Digital Health Integration: Telemedicine and mobile health apps are facilitating ART consultations and remote patient management.
Global Assisted Reproductive Technology: Market Segmentation Analysis
This report provides a deep insight into the global Assisted Reproductive Technology, covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trconclude, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis supports the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and assessing the position of the business organization. The report structure also focutilizes on the competitive landscape of the Global Assisted Reproductive Technology. This report introduces in detail the market share, market performance, product situation, operation situation, etc., of the main players, which supports the readers in the indusattempt to identify the main competitors and deeply understand the competition pattern of the market.
Competitor Analysis (in brief)
Leading companies in the ART market include:
- Vitrolife: Known for its IVF media and fertility devices.
- Ferring Pharmaceuticals: A major supplier of fertility medications.
- Cook Medical: Offers a broad range of ART-related surgical instruments.
- Irvine Scientific: Specializes in culture media for gametes and embryos.
- EMD Serono: A leading provider of injectable hormones for ART.
Market Segmentation (by Application)
- Fertility Clinics
- Hospitals
- Others
Market Segmentation (by Type)
- General
- Fertility Medication
- In Vitro Fertilization
- Others
Key Company
- Vitrolife
- Ferring Pharmaceuticals
- Irvine Scientific
- Cook Medical
- CellCura
- EMD Serono
- Esco Micro
- IKS International (Gonagen Medikal)
- INVO Bioscience
- IVFtech
- Smiths Medical
Geographic Segmentation
North America
Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
South America
- Brazil
- Argentina
- Rest of South America
Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Recent Developments in the Assisted Reproductive Technology (ART) Market
- Advancements in AI-Powered Embryo Selection
In 2024, fertility clinics launched adopting AI algorithms to enhance embryo selection processes during IVF. These technologies support improve success rates by analyzing embryo quality with higher accuracy. - Introduction of At-Home Fertility Testing Kits
Companies like Modern Fertility and Everlywell have expanded their at-home testing services, offering utilizers more accessible and private fertility assessments, boosting awareness and early intervention for reproductive issues. - Cryopreservation Innovations
Breakthroughs in egg and embryo freezing techniques, including vitrification, are improving the long-term viability of preserved reproductive materials, expanding the scope of fertility preservation for cancer patients and women delaying childbirth. - Regulatory Approvals and Global Expansion
In 2025, major ART service providers gained regulatory approvals to expand services into emerging markets such as Southeast Asia, Latin America, and Eastern Europe, where demand for fertility treatments is growing rapidly. - Personalized Medicine and Hormonal Protocols
Fertility centers are increasingly adopting personalized ovarian stimulation protocols based on genetic and hormonal profiles, which has resulted in fewer complications and improved patient satisfaction rates.
Download FREE Sample Report:
Assisted Reproductive Technology Market – View Detailed Research Report
Cryostat Microtome Blades Market
About Intel Market Research
Intel Market Research delivers actionable insights in healthcare and life sciences markets. Our data-driven analysis leverages:
- Primary research with fertility clinics and hospitals
- Technology adoption benchmarking
Market ininformigence across 80+ countries
Trusted by healthcare leaders for strategic decision-creating
International: +1(332) 2424 294 | Asia: +91 9169164321
Website: https://www.intelmarketresearch.com
Follow us on LinkedIn: https://www.linkedin.com/company/intel-market-research
Leave a Reply